nView to Showcase Clinical Workflow Engine Solution at APA 2022


nView invites all APA 2022 attendees to come to Booth 1121 and see how nView helps providers efficiently and accurately assess, diagnose and monitor mental illness.

“APA 2022 provides us with a terrific opportunity to demonstrate to attendees how our new solution helps providers get the right answers at the right time to enable the right mental health outcomes and why we believe ‘healthy minds start with nView.'” – John Letter, nView CEO

nView Health, developer of the premier evidence-based behavioral health solution that combines gold-standard measurements on a single, modern platform, invites attendees of APA 2022, the annual meeting of the American Psychological Association (APA), to visit with nView at Booth 1121. There they can see how nView’s newest solution introduces an innovative approach to mental healthcare with digital workflows based that produce actionable data.

The intelligent workflow engine captures and shares data at every step of the behavioral healthcare process, providing insight to help providers assess and diagnose mental illness and determine the next steps to take in a patient’s care based on the conditions for which the patient meets criteria. This leads to a significant result: better outcomes for patients who suffer from mental illness.

The nView solution supports every stage of the clinical process:


  • Workflow technology — Use one tool to assess multiple conditions. Electronic behavioral health assessments and treatment processes are configurable within existing workflows to help accurately and efficiently screen, diagnose, treat and monitor patients.
  • Gold-standard measures — Validated tools inspire confidence in the delivery of timely, appropriate care. nView is the exclusive licensee of many of the world’s leading digital behavioral health scales and measurements used in clinical and academic research for more than 25 years.
  • Decision support — Evidence-based workflow technology uses algorithms to deliver data when needed to make informed decisions.
  • Clinical outcomes — With verifiable data, more easily provide the right follow-up care, including patient handoffs, coordination of services and measurement-based care.

“At nView, we are helping practitioners, researchers, educators and applied psychologists better assess, treat and deliver outcomes for their patients with mental illness,” said nView CEO John Letter. “APA 2022 provides us with a terrific opportunity to demonstrate to attendees how our new solution helps providers get the right answers at the right time to enable the right mental health outcomes and why we believe ‘healthy minds start with nView.'”

To arrange an in-person demo or meeting with an nView representative at APA 2022, please contact us.

ABOUT NVIEW HEALTH

nView Health is the premier provider of evidence-based software and supporting solutions used by research organizations and healthcare professionals around the world to help them identify, treat and monitor mental health disorders — a critical requirement for measurement-based care. nView is the exclusive licensee worldwide for a broad array of behavioral health screening solutions, structured interviews, and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit nview.com or follow nView Health on LinkedIn or Twitter.

Share article on social media or email:



Leave a Reply